Stop wasting your money on KODK
Is your money at stake?? | | | | Potentially Make $4,946 Before the Weekend | | | Let's face it… the economy is rapidly sinking, and growing your net worth is dang near impossible.
What you need is a steady and reliable income to ensure you can keep your head above water during the hard times ahead.
My two-click system can do that and more by almost guaranteeing thousands of dollars worth of profits every week.
So forget about just getting by, start actively growing your wealth and savings today.
| | | | | Lance Ippolito, Editor - Future of Wealth
Lance is a professional trader and a successful entrepreneur with over 10 years of experience in the financial markets. | | | | | |
I'm not even going to go into the CEO's announcement on The Wall Street Journal to push forward in making ingredients for generic drugs, with or without a $765 million government loan deal (to each their own I suppose).
On Monday, the Kodak CEO Jim Continenza tweeted he'd be live on The Wall Street Journal's Tech Live to discuss the future of Kodak.
After the CEO's tweet, the stock rallied about 50 cents higher on that news alone.
This goes to show you exactly what kind of market we're in nowadays — all a public company has to do to get their stock to trade higher is tweet out when their next public appearance is.
But I just can't seem to buy into what Kodak's trying to sell me: All I'm seeing is junk and the possibility that the company could have given insiders and it's board members "spring-loaded" options before the $765 million U.S. pharmaceutical deal with the company was even announced.
The company's slogan may be "You Press the Button, We Do the Rest," but I don't think I'll be pressing this stock's button anytime soon.
And now Kodak is following a similar path that we witnessed with Hertz Global Holdings Inc (NYSE: HTZ) during its downfall… | | | | Why there's no value in Kodak |
|  | | | | |  | The Best COVID-19 Vaccine Stock to Buy October 20, 2020
People keeping up with the race already know Pfizer was one of the nine companies in September that took a stance to "stand with science" and not rush a vaccine that hasn't been properly vetted.
The Food and Drug Administration is insisting on companies having at least two months of data on half of the people participating in the trial after their final dose before approving the Emergency Use Authorization.
Pfizer announced Friday it won't apply its vaccine for emergency authorization until after the election — despite President Donald Trump insisting we would have a cure before the elections.
However, of the four companies currently in the late-stage testing phase of their vaccines, Pfizer's aggressive timeline goals are beating Moderna Inc. (Nasdaq: MRNA), AstraZeneva Plc. (Nasdaq: AZN) and Johnson & Johnson (NYSE: JNJ).
With so many eyes on this company the past few months, the stock market has begun to take notice… and so has Joshua Belanger.
You see, after taking a look at the charts he noticed a major coronavirus vaccine play being made with the pay-off potential of $7.2 million… in the next 38 days… on a $1.1 million outlay.
| |  | Robinhood Stocks You'll Regret Not Getting October 21, 2020 It has become pretty clear that Robinhood traders — and the apps' top stocks — are a force to be reckoned with.
In fact, it has already scaled up to 13 million users this year alone!
But even if you place your trades on a different platform, you've probably bumped into a penny stock or even two that caught your attention.
WealthPress Head Trader Roger Scott thinks these two penny stocks on Robinhood are the best bet for fat-cat profits…
| | | | | | A New Money Crew Publication | Disclaimer & Disclosures
The information in this email is intended for informational purposes only and does not guarantee specific results as there is a high degree of risk involved with trading. Also, our traders are real traders and may have financial interests in the companies discussed. Please see our Terms and Conditions for more information.
Brought to you by WealthPress. | | | | |
0 Response to "I’m Calling ππ© on This Stock"
Post a Comment